MedPath

PolyMyXin-B direct hemoperfusion OPTimal Initiation timing with Catecholamine study (PMX-OPTIC study)

Not Applicable
Conditions
Septic shock
Registration Number
JPRN-UMIN000051464
Lead Sponsor
Teikyo University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
600
Inclusion Criteria

Not provided

Exclusion Criteria

1. Cases of End of Life/Terminal Care where treatment was not the primary objective. 2. Patients who received interventions for circulatory support such as ECMO, VAD, IMPELLA (excluding IABP).

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath